Analyst Ratings for Protara Therapeutics (TARA)
TARA Rating Summary
TARA Price Target Summary
- Highest: $27.00 (JPMorgan)
- Lowest: $23.00 (H.C. Wainwright)
- Average: $24.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$24.75 (+319.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$24.75 (+319.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | JPMorgan | Brian Cheng | New Coverage | Overweight (N/A) |
27.00 (N/A) |
5.97 (5.90) |
-1.17% | Details |
| 1/7/2026 | Piper Sandler | Kelsey Goodwin | New Coverage | Overweight (N/A) |
24.00 (N/A) |
5.39 (5.90) |
9.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
